A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic
Clinical trial NCT05527964 · COMPLETED
Trial details
- NCT number
- NCT05527964
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-30
- Primary completion
- 2025-06-16
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.